- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.63 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:S.12, A:S.12, A:S.12, A:W.357, A:D.358
- Water bridges: A:E.349, A:R.353, A:R.353, A:S.356
- Salt bridges: A:R.353
SO4.4: 2 residues within 4Å:- Chain A: R.44, S.45
3 PLIP interactions:3 interactions with chain A- Water bridges: A:R.44, A:S.45
- Salt bridges: A:R.44
SO4.5: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
7 PLIP interactions:7 interactions with chain A- Water bridges: A:K.79, A:K.79, A:R.277, A:R.277
- Salt bridges: A:K.79, A:R.277, A:H.306
SO4.6: 3 residues within 4Å:- Chain A: T.63, G.64, Q.440
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.440, A:Q.440
SO4.7: 5 residues within 4Å:- Chain A: Y.11, W.348, E.349, Q.350, R.353
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:Y.11, A:Y.11, A:W.348, A:Q.350
- Water bridges: A:R.353
- Salt bridges: A:R.353
SO4.9: 2 residues within 4Å:- Chain A: R.329, L.330
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.329
SO4.12: 2 residues within 4Å:- Chain A: E.254, R.257
2 PLIP interactions:2 interactions with chain A- Water bridges: A:R.257
- Salt bridges: A:R.257
SO4.16: 2 residues within 4Å:- Chain A: H.290, K.293
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.290, A:K.293
SO4.18: 3 residues within 4Å:- Chain A: T.43, S.45, R.47
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.43, A:T.43, A:S.45
- Salt bridges: A:R.47
SO4.26: 6 residues within 4Å:- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:S.12, B:S.12, B:S.12, B:W.357, B:D.358
- Water bridges: B:E.349, B:E.349, B:R.353, B:S.356
- Salt bridges: B:R.353
SO4.27: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
8 PLIP interactions:8 interactions with chain B- Water bridges: B:K.79, B:W.228, B:R.277, B:R.277, B:H.306
- Salt bridges: B:K.79, B:R.277, B:H.306
SO4.28: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.194, B:G.243
SO4.29: 2 residues within 4Å:- Chain B: R.44, S.45
3 PLIP interactions:3 interactions with chain B- Water bridges: B:R.44, B:S.45
- Salt bridges: B:R.44
SO4.37: 3 residues within 4Å:- Chain B: A.1, R.2, S.25
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.25, B:S.25
- Salt bridges: B:R.2
SO4.43: 3 residues within 4Å:- Chain B: L.165, P.171, V.172
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:V.172
- Water bridges: B:L.165, B:A.168, B:V.172
- 24 x ACT: ACETATE ION(Non-functional Binders)
ACT.8: 2 residues within 4Å:- Chain A: R.44, Y.487
Ligand excluded by PLIPACT.10: 3 residues within 4Å:- Chain A: E.111, R.170, P.428
Ligand excluded by PLIPACT.11: 2 residues within 4Å:- Chain A: T.252, H.255
Ligand excluded by PLIPACT.13: 4 residues within 4Å:- Chain A: Q.226, H.273, N.275, V.276
Ligand excluded by PLIPACT.14: 2 residues within 4Å:- Chain A: H.274, N.275
Ligand excluded by PLIPACT.15: 3 residues within 4Å:- Chain A: F.75, H.328, H.374
Ligand excluded by PLIPACT.17: 2 residues within 4Å:- Chain A: Q.207, R.211
Ligand excluded by PLIPACT.19: 2 residues within 4Å:- Chain A: A.438, N.442
Ligand excluded by PLIPACT.21: 3 residues within 4Å:- Chain A: R.277, V.305, H.306
Ligand excluded by PLIPACT.22: 3 residues within 4Å:- Chain A: T.187, K.198, G.199
Ligand excluded by PLIPACT.23: 4 residues within 4Å:- Chain A: R.285, P.319, A.320, T.369
Ligand excluded by PLIPACT.24: 5 residues within 4Å:- Chain A: F.31, S.455, L.493, W.494, H.495
Ligand excluded by PLIPACT.25: 4 residues within 4Å:- Chain A: W.312, Y.313, C.342, Q.362
Ligand excluded by PLIPACT.30: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
Ligand excluded by PLIPACT.31: 3 residues within 4Å:- Chain B: I.158, P.159, H.162
Ligand excluded by PLIPACT.32: 5 residues within 4Å:- Chain B: Q.226, T.272, H.273, N.275, V.276
Ligand excluded by PLIPACT.33: 2 residues within 4Å:- Chain B: H.290, K.293
Ligand excluded by PLIPACT.34: 1 residues within 4Å:- Chain B: R.262
Ligand excluded by PLIPACT.35: 3 residues within 4Å:- Chain B: S.464, S.465, Y.487
Ligand excluded by PLIPACT.36: 5 residues within 4Å:- Chain B: L.67, L.436, A.438, N.442, L.444
Ligand excluded by PLIPACT.38: 2 residues within 4Å:- Chain B: E.254, R.257
Ligand excluded by PLIPACT.39: 1 residues within 4Å:- Chain B: R.277
Ligand excluded by PLIPACT.40: 1 residues within 4Å:- Chain B: Q.207
Ligand excluded by PLIPACT.44: 3 residues within 4Å:- Chain B: D.315, W.348, E.349
Ligand excluded by PLIP- 2 x HK2: (1~{S},3~{S},4~{R},6~{R})-2,3,4,6-tetrakis(oxidanyl)-5-[[4-[3-(4-phenylphenoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexan-1-olate(Covalent)
HK2.20: 11 residues within 4Å:- Chain A: D.127, F.128, W.179, N.234, E.235, F.246, Y.313, E.340, C.342, W.381, N.396
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:Y.313, A:Y.313, A:E.340
- Hydrogen bonds: A:D.127, A:W.179, A:N.234, A:E.235, A:Y.313, A:N.396
- Water bridges: A:E.235
HK2.42: 13 residues within 4Å:- Chain B: D.127, F.128, W.179, N.234, E.235, F.246, D.315, E.340, C.342, V.343, W.381, N.396, V.398
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:E.340
- Hydrogen bonds: B:D.127, B:W.179, B:N.234, B:E.235, B:N.396
- Water bridges: B:E.235, B:E.235, B:E.235
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Artola, M. et al., Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. J.Am.Chem.Soc. (2019)
- Release Date
- 2019-03-27
- Peptides
- Glucosylceramidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 6q6n.1
Crystal structure of recombinant human beta-glucocerebrosidase in complex with biphenyl-cyclophellitol inhibitor (ME655)
Glucosylceramidase
Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.6 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 more...less...3gxd.1 | 3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.2 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q1p.3 | 6q6k.1 | 6q6l.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2